Hamid Khoja, Chief Scientific Officer at FibroBiologics, Inc. (FBLG), bought 20,000 shares at $0.84 ($17K) on 2025-05-27, disclosed to the SEC on 2025-05-27.
Open-market purchase of $17k FBLG by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |